Vonoprazan-amoxicillin dual therapy vs. proton pump inhibitor based dual therapy for Helicobacter pylori eradication: a meta-analysis
Background and objectiveIn recent years, the use of high-dose dual therapy based on PPI and amoxicillin (PPI-HDDT) has shown satisfactory efficacy in eradicating Helicobacter pylori (H. pylori) as a first-line treatment. Vonoprazan (VPZ), a new potassium-competitive acid blocker, exhibits rapid, pot...
Na minha lista:
| Principais autores: | , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Frontiers Media S.A.
2026-01-01
|
| 叢編: | Frontiers in Medicine |
| 主題: | |
| 在線閱讀: | https://www.frontiersin.org/articles/10.3389/fmed.2025.1739284/full |
| 標簽: |
沒有標簽, 成為第一個標記此記錄!
|